Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
DMK Pharmaceuticals (DMKPQ)
OTHER OTC:DMKPQ
DMK Pharmaceuticals (DMKPQ) Stock Price & Analysis
1,106 Followers
DMKPQ Stock Chart & Stats
Day’s Range$0.03 - $0.05
52-Week Range― - ―
Previous Close$0.03
Volume15.82K
Average Volume (3M)N/A
Market Cap
$336.40K
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next Earnings
May 13, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
DMKPQ FAQ
What was DMK Pharmaceuticals’s price range in the past 12 months?
Currently, no data Available
What is DMK Pharmaceuticals’s market cap?
Currently, no data Available
When is DMK Pharmaceuticals’s upcoming earnings report date?
DMK Pharmaceuticals’s upcoming earnings report date is May 13, 2024 which is in 10 days.
How were DMK Pharmaceuticals’s earnings last quarter?
Currently, no data Available
Is DMK Pharmaceuticals overvalued?
According to Wall Street analysts DMK Pharmaceuticals’s price is currently Overvalued.
Does DMK Pharmaceuticals pay dividends?
DMK Pharmaceuticals does not currently pay dividends.
What is DMK Pharmaceuticals’s EPS estimate?
DMK Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does DMK Pharmaceuticals have?
Currently, no data Available
What happened to DMK Pharmaceuticals’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of DMK Pharmaceuticals?
Among the largest hedge funds holding DMK Pharmaceuticals’s share is Greenlight Capital Inc. It holds DMK Pharmaceuticals’s shares valued at N/A.
---
DMK Pharmaceuticals Stock Smart Score
Company Description
DMK Pharmaceuticals
Adamis Pharmaceuticals Corp. is a biopharmaceutical company, which engages in the discovery, development and sales of pharmaceutical, specialty biopharmaceutical and other drug products. It offers Symjepi product for allergy, respiratory, opioid overdose, and erectile dysfunction (ED), markets. The company was founded in June 2006 and is headquartered in San Diego, CA.
---
DMKPQ Earnings Call
Q1 2023
0:00 / 0:00
---
DMKPQ Stock 12 Months Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering DMKPQ
1 Year
1 Year Success Rate
0/1 ratings generated profit
1 Year Average Return
-94.40%
initiated a buy rating 5 months ago
Copying Michael Okunewitch's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -94.40% per trade.
---